Hosted on MSN15d
Driver of aggressive tumours discovered, pancreas firstThe study could open the door to new treatments capable of selectively targeting cells with mesenchymal characteristics and thus depriving the tumor of its main driver. The discovery, published in ...
Researchers at Karolinska Institutet, led by Dr. Helin Norberg and Dr. Erik Norberg, have identified a previously unknown ...
A Phase Ia Dose-Escalation Study The article by Mascarenhas et al entitled “Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors” (J ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback